Koyfin Home > Directory > Health Care > Iovance Biotherapeutics Inc > Cash and Short-Term Investments

Iovance Biotherapeutics Inc Cash and Short-Term Investments Chart (IOVA)

Iovance Biotherapeutics Inc annual/quarterly Cash and Short-Term Investments from 2010 to 2020.
  • Iovance Biotherapeutics Inc Cash and Short-Term Investments for the quarter ending September 09, 2020 was $714m a 57.00% increase of 407m year over year
  • Iovance Biotherapeutics Inc Cash and Short-Term Investments for the last 12 months ending September 09, 2020 was $714m a 57.00% increase of 407m year over year
  • Iovance Biotherapeutics Inc Annual Cash and Short-Term Investments for 2019 was $307m a -52.57% decrease of -161m from 2018
  • Iovance Biotherapeutics Inc Annual Cash and Short-Term Investments for 2018 was $469m a 68.97% increase of 323m from 2017
  • Iovance Biotherapeutics Inc Annual Cash and Short-Term Investments for 2017 was $145m a -14.51% decrease of -21m from 2016
Other Balance Sheet Metrics:
  • Iovance Biotherapeutics Inc Total Assets for the quarter ending September 09, 2018 was $271m a 42.63% increase of 115m year over year
  • Iovance Biotherapeutics Inc Other Liabilities for the quarter ending March 03, 2014 was $0m
  • Iovance Biotherapeutics Inc Total Equity for the quarter ending September 09, 2018 was $271m a 46.23% increase of 125m year over year
View Chart On Koyfin

Quarterly IOVA Cash and Short-Term Investments Data

09/2020$714m
06/2020$772m
03/2020$246m
12/2019$307m
09/2019$362m
06/2019$404m
03/2019$440m
12/2018$469m
09/2018$260m
06/2018$276m

Annual IOVA Cash and Short-Term Investments Data

2019$307m
2018$469m
2017$145m
2016$166m
2015$104m
2014$45m
2013$20m
2012$0m
2011$1m
2010$1m